SAN DIEGO, April 25, 2016 /PRNewswire/ -- Sequenom,
Inc. (NASDAQ: SQNM), a life sciences company committed to enabling
healthier lives through the development of innovative products and
services, today announced it will report financial results for the
first quarter 2016 after closing of the NASDAQ Global Market on
Wednesday, May 4, 2016.
A conference call hosted by Dr. Dirk van
den Boom, President and CEO, and other members of senior
management will take place on Wednesday, May
4, 2016, at 5:00 p.m. ET
(2:00 p.m. PT) and will be webcast
live on the Sequenom Website.
Call participants should dial 877-883-0383 (U.S. / Canada) or 412-902-6506 (other countries).
Please use code 4043466. A telephonic replay will be available
through June 3, 2016 by dialing
877-344-7529 (US toll free), 855-669-9658 (Canada toll free), or 412-317-0088
(international toll), and entering the conference number
10085264.
The conference call webcast is also accessible through the
"Investors" section of the Sequenom Website at
http://sequenom.investorroom.com/webcasts
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a pioneering genetic testing
company dedicated to women's health through the development of
innovative products and services. The Company serves patients
and physicians by providing early patient management
information. For more information, visit
www.sequenom.com.
About Sequenom Laboratories
Sequenom Laboratories, a CAP-accredited and CLIA-certified
molecular diagnostics laboratory, has developed a broad range of
laboratory tests, with a focus principally on prenatal care.
Branded under the names HerediT®, HerediT®
UNIVERSAL, MaterniT® GENOME, MaterniT21®
PLUS, NextView®, SensiGene® and
VisibiliT™, these molecular genetic laboratory-developed
tests provide early patient management information for
obstetricians, geneticists, and maternal fetal medicine
specialists. Sequenom Laboratories is changing the landscape in
genetic diagnostics using proprietary cutting edge technologies.
Visit www.laboratories.sequenom.com and follow @SequenomLabs.
SEQUENOM®, HerediT®,
MaterniT® GENOME, MaterniT21® PLUS,
NextView®, SensiGene®, VisibiliT™
and Sequenom Laboratories™ are trademarks of Sequenom,
Inc. All other trademarks and service marks are the property of
their respective owners.
Logo - http://photos.prnewswire.com/prnh/20160225/337675LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-schedules-first-quarter-results-conference-call-for-may-4-2016-300257178.html
SOURCE Sequenom, Inc.